You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Azerbaijan

Jun 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Azerbaijan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Azerbaijan, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Azerbaijan for free:

The Consumer Health in Azerbaijan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Azerbaijan?
  • What are the major brands in Azerbaijan?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

The market continues to grow due to rising demand

In 2010, the value of the consumer health market in Azerbaijan increased further. Both imported and locally produced remedies increased in price, however the increase was not constant, limited to seasons. The market growth was stimulated by the H1N1 flu epidemic in Azerbaijan which started in November 2009, influenced by the epidemic in Ukraine, Russia, Turkey and Georgia. High activity of the local mass media led to panic in society. Most pharmacies sold out off most anti-flu and related medicines within several days. Some pharmacies significantly raised the prices during that period. The habit of self-medicating also had a positive influence on sales growth. Consequently, relative state authorities increased raids of those pharmacies which abused that panic and substantially increased unit prices. They applied sanctions for those stores in line with controlling their legal operations (existence of license).

Launch of new brands slightly slowed down

Despite advertising of pharmaceutical products being forbidden, the promotion of Panadol at a reduced price was strongly conducted through TV channels during September and October 2010. Apart from that, companies could only distribute promotional materials and arrange informative meetings for health professionals. Those who view cable TV channels have the opportunity to see advertising of OTC healthcare medicines through Russian TV, contributing to the expansion of the market position of foreign companies. However, one of the results of the financial instability was a notable lack of new brands and products in 2010. In previous years, new product launches were seen across a number of categories. In 2010, novelties ceased with few exceptions. Analgesics, cough, cold and allergy (hay fever) remedies, medicated skin care, vitamins and dietary supplements and slimming products were those to offer a few launches.

Despite expansion of locals, imports continue to drive overall sales

The consumer health market was quite fragmented in Azerbaijan with the presence of a large number of multinationals. Despite domestic medicinal products expanding, including various topical analgesic ointments, herbal-based oils, skin care gels and creams, multinationals led the market. Those domestic companies that have comparatively greater financial resources have upgraded their production facilities; these include Bioil Ltd, Herba-Flora Co and Azerfarma Ltd. However, Actavis Group, Bristol-Myers Squibb Co, Marion Biotech Pvt Ltd, GlaxoSmithKline Plc, Bayer AG and Nycomed Group remain the leading players in 2010 due to the companies’ strong positions, particularly in cough, cold and allergy remedies, analgesics, medicated skin care, vitamins and dietary supplements and smoking cessation aids.

Parapharmacies/drugstores dominates consumer health sales

Distribution of medicines remained strictly state-controlled and regulated by legislation. Convenience and timesaving are the main factors driving parapharmaceuticals, as consumers have a chance to purchase toiletries, cosmetics, personal hygiene products there alongside medicinal products. A popular format that emerged in Baku in 2009 is the pharmaceutical “supermarket”, offering medicines (OTC and Rx), cosmetics, toiletries and foods, with Avis Tibb Market remaining a leader in that segment. However, unit prices are higher there and the sale is limited to the higher-income consumer group.

Interest of foreign companies and state reforms will drive the market

Consumer healthcare is expected to see on-going good constant value growth during the forecast period. Growth is expected to be underpinned by the on-going health and wellness trend in the country. Foreign companies will continue to support their consumer healthcare products with heavy advertising and promotion. This included not only traditional booklets but also educational training for doctors and pharmacists. All this will contribute to the expansion of the market position of foreign companies. Besides, as a result of various state reforms and convenient credit crunch, more domestic companies, following European standards, will buy new equipment, upgrade the production processes and start to be active in the development of new products.

Table of Contents

Table of Contents

Consumer Health in Azerbaijan - Industry Overview

EXECUTIVE SUMMARY

The market continues to grow due to rising demand

Launch of new brands slightly slowed down

Despite expansion of locals, imports continue to drive overall sales

Parapharmacies/drugstores dominates consumer health sales

Interest of foreign companies and state reforms will drive the market

KEY TRENDS AND DEVELOPMENTS

H1N1 Flu caused a panic in society and created potential for market growth

Still a slight attempt to change channels of distribution

Government improves regulation of consumer healthcare

Growing interest in health and wellness despite obesity remain

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

De-listing or de-reimbursement

Traditional remedies

Combination products

Advertising

Packaging and labelling

Distribution

Vitamins and dietary supplements registration and classification

Advertising

Packaging and labelling

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2009-2010

DEFINITIONS

Sources

  • Summary 2 Research Sources

Consumer Health in Azerbaijan - Company Profiles

AvroMed LLC in Consumer Health (Azerbaijan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Lider Farm MMC in Consumer Health (Azerbaijan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 7 Lider Farm MMC: Competitive Position 2010

Meri-Dian MMC in Consumer Health (Azerbaijan)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Adult Mouth Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • The low popularity of the category largely affects adult mouth care sales in the country. Traditional methods to treat mouth ailments, such as gargling with soda and putting honey around the place of a mouth ulcer with the tip of the tongue are still popular substitutions for using standard medicines.

SWITCHES

COMPETITIVE LANDSCAPE

  • Unique Pharmaceutical Laboratories is strong leader in adult mouth care, accounting for a 30% value share in 2010 with its Metrogyl brand. This player was first mover in adult mouth care in 2001 and supported strong product category growth through wider distribution coverage and advertising through booklets.

PROSPECTS

  • Adult mouth care products will be used more intensively by consumers to prevent further disease development, applying premium- and standard-priced branded products. However, advertising and consumer education will be important for boosting future sales.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Adult Mouth Care Company Shares 2006-2010
  • Table 14 Adult Mouth Care Brand Shares 2007-2010
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, combination products analgesics turned out to still be popular among consumers. Many consumers are more inclined to get rid of any pains, incidence of stress-related headaches and muscular tension, quickly. Declining disposable income levels and long hours at work to earn additional money resulted in higher stress levels for many, which in turn created tension headaches and muscular pain. This particularly boosted sales of combination products catering to a wide range of symptoms and also of topical analgesics/anaesthetic.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010, Bristol-Myers Squibb Co continued leading the category with a 21% value share with its Aspirin UPSA, Efferalgan and Upsarin brands, followed by Marion Biotech Pvt Ltd (Cinepar) with 17% and Actavis Group (Troxevasin 2%, Topogel 2.5%, Spazmalgon slightly over than 1%) with a 12% value share. The brands are well-known and long-standing ones, which have been present on the market for years.

PROSPECTS

  • Over the forecast period, consumers are expected to be more selective and continue to demand the products that produce the quickest effects at the cheapest prices. Thus, constant value growth rates are expected to be higher over the forecast period.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2005-2010
  • Table 18 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 19 Analgesics Company Shares 2006-2010
  • Table 20 Analgesics Brand Shares 2007-2010
  • Table 21 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, growth was further increased due to the stress-related sleeping problems caused by financial instability, which increased the demand for these products. Furthermore, rising stress of urban living and working life also contributed to the growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Yaroslavskaya Farmatsevticheskaya Fabrika ZAO led the category with a 27% value share and also gained the largest increase by three percentage points in value share in 2010. The company’s Nastoyka Boyarishnika (aglet tincture) and Nastoyka Pustirnika (motherwort tincture) are based on traditional herbs, containing aglet and motherwort. It has a strong customer base in the country and enjoys good customer loyalty, due to their traditional presence and cheaper prices. Those tinctures have been well known to a large audience since Soviet times.

PROSPECTS

  • Over the forecast period, constant value sales of calming and sleeping products are expected to increase at a CAGR of 3% to reach AZN1.6 million in 2015. Growth will be supported by intensifying stress, which is interrelated with further economic growth in the country during the forecast period and simultaneously, a growing focus on career and longer working hours in Baku and large cities of Azerbaijan.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2005-2010
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 25 Calming and Sleeping Company Shares 2006-2010
  • Table 26 Calming and Sleeping Brand Shares 2007-2010
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, cough, cold and allergy remedies brands have become very well known, as most are advertised heavily through Russian TV channels, especially during the winter months and pollen season. These brands are Doctor Mom, Coldrex, Fervex, ACC, Strepsils, Dlyanos, Faringosept and Dr Theiss Nazolin. Due to that, the level of self-medication continued to grow in Azerbaijan and as a result, consumption of well-known cough, cold and allergy remedies increased. This is particularly the case for products treating symptoms of common colds and flu.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer AG led cough, cold and allergy (hay fever) remedies with a 13% value share, followed by Reckitt Benckiser and Nycomed Pharma with value shares of 9% in 2010. Sagmel Inc, which ranked fifth in overall cough, cold and allergy (hay fever) remedies in 2007, was acquired in June 2008 by Bayer AG’s Customer Care Division. The company thus became part of Bayer HealthCare, enabling Bayer to extend in cough, cold and allergy (hay fever) remedies. Sagmel offers a wide range of products, including antihistamines/allergy remedies (systemic), cough remedies, combination products and nasal sprays. After acquisition, Bayer AG ranked fifth in 2008 and jumped up to the leading position in 2009 and 2010.

PROSPECTS

  • Cold winter season, the symptoms of coughs and colds, alertness, common or specific flu types will be the main drivers of the category over the forecast period. Even coming into contact with a person with mild symptoms of a cold or common flu will increase the other person’s concern and anxiety, with many thus opting for cough, cold and allergy (hay fever) remedies. Many will strive to recover as quickly as possible, in the hope of thus maintaining a strong immune system and thus remaining more resistant to stronger viruses.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, consumers still suffered from digestive disorders and discomfort, which are more linked to increasingly fast-paced lifestyles and rising stress. Consumers increasingly found themselves spending more time commuting, which reduced the time available to prepare and eat meals themselves, which drives the sales performance of fast food outlets. Stress also resulted in many suffering from digestive discomfort. This was due to the inevitable stress of living in large cities with overcrowded transport routes and housing.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2010, Sanofi-Aventis drove Ukrmedprom DAK with its Nastoyka Myati Perechnoy brand (mint tincture) from the leading position which the company held in previous year. Sanofi-Aventis was the second-ranking company in 2009 and managed to lead the category during 2010, achieving a 17% value share. This was largely thanks to the strong performance of the company’s No-spa brand in IBS treatments and Festal brand in antiflatulents. No-spa was traditionally viewed as a spasmolytic by many consumers which relieves a stomach ache.

PROSPECTS

  • Compared to the value sales of the review period, the constant value sales over the forecast period will demonstrate a higher growth rate. This is largely due to the lower quality of food, expansion of fast food channels which in some cases do not follow hygienic regulations, especially in the hot summer time, and rising popularity of diets which in some cases have a negative impact on the stomach and intestines. Hence the total number of gastrointestinal problems is expected to increase which will increase in turn the demand for more qualitative digestive remedies at higher unit prices.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 37 Digestive Remedies Company Shares 2006-2010
  • Table 38 Digestive Remedies Brand Shares 2007-2010
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, complications of flu and angina increased among consumers in the country. This is mostly due to the increasing level of self-medication of colds, angina and flu underpinned by dynamic lifestyles and lack of time to stay at home and make sure that the illness is completely over. This careless treatment complicates the behaviour of the illness, causing ear-nose-throat-related problem. This in turn increased the demand for medicated ear drops. Thus, the number of ear care brands increased during 2010, mostly within premium brands, such as Otofa and Polydexa from Laboratoires du Docteur E Bouchara and standard-priced brand Otinum 20% from ICN Pharmaceutical Inc.

SWITCHES

COMPETITIVE LANDSCAPE

  • Aventis SA led the category at the end of the review period. The company’s Sofradex brand is the best recognised product in ear care and it also achieved the highest share growth in 2010 over the previous year. Laboratoires Biocodex SA ranked second and its Otipax brand follows Aventis’s Sofradex closely. Leading brands in the category are long established and brand reputation plays the most important role in sales.

PROSPECTS

  • Ear care is expected to grow at a constant value CAGR of 1% over the forecast period. People will still prefer to visit the doctor even for minor ear problems. But next time the same ailment occurs, consumers will likely purchase the medicines without prescription.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2005-2010
  • Table 42 Sales of Ear Care: % Value Growth 2005-2010
  • Table 43 Ear Care Company Shares 2006-2010
  • Table 44 Ear Care Brand Shares 2007-2010
  • Table 45 Forecast Sales of Ear Care: Value 2010-2015
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Azerbaijan - Category Analysis

TRENDS

  • Emergency contraception is still undeveloped in Azerbaijan. The most important factors that hamper the development of this category are low awareness, religion and cultural aspects. However, at the end of the review period, there was an active, educational advertising campaign stressing the fact that it is not a problem to prevent pregnancy after unprotected sexual intercourse.

PROSPECTS

  • Judging from the activity expressed in this educational advertising campaign and various TV talk shows devoted to this subject, there is an indication that within a few years of the forecast period, some emergency contraception products could be introduced as OTC.

Eye Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, the number of people who work with computers has been growing, which results in an increase in the number of people with eye irritations (red and dry eye discomforts). Long working hours with computers or lack of sleep steadily increase the demand for eye care products. Consequently, the category witnessed a flow of new brands during 2010, which are Tears Naturale II from Alcon-Couvreur nvsa, Dexamethasone from Farmak VAT and Fotil Forte from Santen Pharmaceutical Co Ltd.

SWITCHES

COMPETITIVE LANDSCAPE

  • Egyptian International Pharmaceutical Industries Co SAE (EIPICO) continued to be the leading player in eye care in 2010 with a value share of 20%. It is largely due to the popularity of its two brands Bestoxol and Normatin, its advertising and promotional booklets in pharmacies. It is followed by Alcon Pharmaceuticals Ltd, thanks to the popularity of its Tears Naturale, Tobrex, Alomid, Maxidex, Quinax and Tobradex brands. The company owned the most eye care brands, and held a value share of 14% in 2010.

PROSPECTS

  • Eye care is expected to see further growth, largely due to a greater number of eye problems related with computer use, contact lenses and pollution caused by increased urbanisation.

CATEGORY DATA

  • Table 47 Sales of Eye Care by Category: Value 2005-2010
  • Table 48 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 49 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 50 Eye Care Company Shares 2006-2010
  • Table 51 Eye Care Brand Shares 2007-2010
  • Table 52 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 53 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products have strong traditional appeal in Azerbaijan, especially among rural dwellers, the elderly and low-income groups. Competition between domestic and imported products intensified towards the end of the review period, reflected in the gradual decrease in price differences and improvements in the image and perception of local products.

COMPETITIVE LANDSCAPE

  • Sales were led by Plethico Pharmaceuticals Ltd (Travisil) with a value share of slightly over 16% in value terms, followed by Herba-Flora Co (Herba-Flora) and Yaroslavskaya Farmatsevticheskaya Fabrika ZAO (Nastoyka pustirnika) with 16% and 13% of value shares, respectively. These are traditional products that are well established in Azerbaijani society.

PROSPECTS

  • Constant value growth is expected to increase during the forecast period, increasing at a CAGR of 6%; higher than the constant value CAGR seen during the review period. Further growth will be a result of the broadening of herbal/traditional products’ assortment. Besides, the health and wellness trend may well result in more consumers switching towards herbal/traditional products, believing these products to be more natural and thus healthier. This is expected to particularly benefit herbal/traditional products in dynamic areas where there may be long-term use, such as calming and sleeping products, digestive remedies, and herbal/traditional cough, cold and allergy (hay fever) remedies.

CATEGORY DATA

  • Table 54 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 55 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 56 Herbal/Traditional Products Company Shares 2006-2010
  • Table 57 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 58 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 59 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, the launch rate of new brands slowed down due to the saturation of the market and still higher consumer preference towards habitual medicines, such as yod, brilliant green and other balms and gels. Topical and vaginal antifungals experienced relative stagnation in the launch of new brands, since those categories turned out to be more saturated by 2010. However, the category enjoyed an inflow of new product types, such as sulphur and/or bitumen soap especially designed for acne treatments and also serves as a preventive measure for facial skin.

SWITCHES

COMPETITIVE LANDSCAPE

  • Lider Farm MMC with its popular Erythromicini, Synthomycini and Gentamycini brands remained leader in 2010 with a 17% share of value sales. It enjoys consumer loyalty due to its long-standing high quality products and low prices. It is followed by Janssen Pharmaceutica NV (Johnson & Johnson Inc) with its Nizoral and Clean & Clear brands, enjoying a longstanding presence in the country. The Nizoral brand enjoys strong customer loyalty, having been a pioneer in medicated shampoo.

PROSPECTS

  • Poor nutrition, pollution, increasing incidence of sexually transmitted diseases, availability of beauty salons and gyms where steps for creating a hygienic environment are not properly followed, alongside a growing number of allergy sufferers will contribute to the development of medicated skin care in Azerbaijan. Hence, medicated skin care in Azerbaijan is predicted to continue its dynamic growth over the forecast period.

CATEGORY DATA

  • Table 60 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 61 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 62 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 63 Medicated Skin Care Brand Shares 2007-2010
  • Table 64 Hair Loss Treatments Brand Shares 2007-2010
  • Table 65 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 66 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period tobacco products in Azerbaijan continued to see growth. Further new launches of slim and flavoured cigarettes underpinned demand, particularly amongst women, since females are more receptive to these types of cigarettes. Although promised, Azerbaijan’s national parliament did not enact the new tobacco regulation which would enforce the current anti-tobacco measures in 2010. However, it is expected to be enacted in 2011, by adopting a new law that will ban smoking in any places of entertainment, cafés, restaurants, bars, parks, public transport stops, in corridors and any other enclosed public places where more than four people gather.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sales of NRT smoking cessation aids remained limited to Nicorette, which is present in Azerbaijan only as NRT gum. Tabex from Sopharma AD is the only brand available under herbal/traditional smoking cessation aids. There is no competition for NRT smoking cessation aids from Rx products or a potential Rx-to-OTC switch, as there are no Rx products available. The absence of innovations, lack of advertising and popularisation of the product remain key barriers to stronger growth of NRT smoking cessation aids in Azerbaijan.

PROSPECTS

  • Future prospects for NRT smoking cessation aids are undoubtedly positive. A ban on tobacco advertising and smoking in public places is a positive development already and promotion of a healthy lifestyle will be popularised further in the country by NGO and governmental agencies, especially given that a health and wellness trend is emerging in Azerbaijan. This is a good start-up that needs to be used when advertising NRT smoking cessation aids.

CATEGORY INDICATORS

  • Table 67 Number of Smokers by Gender 2005-2010
  • Table 68 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2010
  • Table 69 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2010
  • Table 70 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 71 NRT Smoking Cessation Aids Company Shares 2006-2010
  • Table 72 NRT Smoking Cessation Aids Brand Shares 2007-2010
  • Table 73 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 74 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • There was a growing focus on health and wellness in Azerbaijan during the review period, with this continuing into 2010 despite the impact of the economic downturn. Hence, the high price of foreign brands coupled with less belief in the promised effect, hampered development of sports nutrition in the country at the end of the review period. On the other hand, growing product awareness, constant range expansion, wider distribution coverage (mainly through parapharmacies that are located in the central part of Baku city) and the increasing number of professional athletes and those who do muscle-building exercises, keep the category afloat.

COMPETITIVE LANDSCAPE

  • Ultimate Nutrition Inc remains the leader in 2010 with a value share of 44%. The company offers a wide range of sports nutrition under the Ultimate Nutrition brand, with products also offered in a wide range of pack sizes, from 400g to 2,250g. This means that consumers can buy bulk packs in order to achieve economies of scale but can also buy more affordable small packs when their funds are low. In addition, the company benefited from wider distribution coverage, introducing many formats of its products, such as powder, capsules and liquid.

PROSPECTS

  • Rising spending power will assist growth of sports nutrition during the forecast period, but low brand awareness and high prices will hamper wider market development. Consequently, sales will continue to be dominated by Baku city during the forecast period, with purchases mainly made by active young men. Women, low-income groups, rural consumers and the elderly will continue to be excluded from sports nutrition during the forecast period.

CATEGORY DATA

  • Table 75 Sales of Sports Nutrition: Value 2006-2010
  • Table 76 Sales of Sports Nutrition: % Value Growth 2006-2010
  • Table 77 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 78 Sports Nutrition Company Shares 2006-2010
  • Table 79 Sports Nutrition Brand Shares 2007-2010
  • Table 80 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 81 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015
  • Table 82 Sports Nutrition Category Rankings 2010

Vitamins and Dietary Supplements in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • During 2010, sales of vitamins and dietary supplements were driven by consumers’ desire to prevent common illnesses such as colds and flu. Sales of vitamins were also stimulated by the growing consumer interest in healthier lifestyles, which increased the use of vitamins that are perceived to prevent eye problems or calcium loss and provide the organism with mineral supplements. Towards the end of the review period, the number of public health campaigns increased in Azerbaijan, mostly through organising various mass media TV programs, promoting the use of vitamins and dietary supplements. The widely advertised brands through such programs are Pikovit, Multi Tabs and Vitrum multivitamins.

Vitamins

Dietary Supplements

COMPETITIVE LANDSCAPE

  • Actavis Group, with a 23% share of retail value sales in 2010, was the leading player in vitamins and dietary supplements, followed by Bayer AG with a 9% share. The latter company benefited from the acquisition of Sagmel Inc. Sagmel offered a wide range of products, including multivitamins and calcium supplements under the Health Life brand range and won both consumer loyalty and awareness. This popularity enabled Bayer to enter the vitamins and dietary supplements category in Azerbaijan.

PROSPECTS

  • Over the forecast period, consumers are expected to increase their consumption of dietary supplements and multivitamins due to growing health concerns. Multinationals will broaden their ranges, offering more specialised brands, encouraging consumers to try new products. Preventing disease is expected to become a more important issue for Azerbaijanis compared to the performance observed over the review period. This trend will be driven by growing disposable income, especially amongst 30-55-year-old consumers.

CATEGORY DATA

  • Table 83 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 84 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 85 Dietary Supplements by Positioning 2006-2010
  • Table 86 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 87 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 88 Vitamins Brand Shares 2007-2010
  • Table 89 Dietary Supplements Brand Shares 2007-2010
  • Table 90 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 91 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015
  • Summary 9 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, busier lifestyles and increasing urbanisation continued to reduce levels of exercise. The desire to achieve quick weight loss without lots of exercise and dieting impacted sales of weight management products. The open discussion of the obesity problem in the health-related programs of mass media, along with advocacy about healthy lifestyles and specific beauty standards both in local and Russian TV programs, encouraged Azerbaijanis – especially females – to become more concerned about their health in general, weight and appearance in particular.

COMPETITIVE LANDSCAPE

  • Herba-Flora Co continued to lead sales of weight management products in 2010, with a value share of 37%. Herba-Flora, the largest local company, experienced a further share increase and recorded the largest increase in current value sales, benefiting from the popularity of its slimming tea brands in Azerbaijan, such as Afrodita, 90-60-90. The popularity of the brands can be explained by strong recognition amongst consumers, confidence in its quality, a reasonable price and wide availability.

PROSPECTS

  • The rising level of information and education about obesity will continue contributing to growth. Consumers will also be increasingly aware of the problems caused by high cholesterol levels. Products that reduce appetite will be more actively used, as will various teas promoting fast digestion.

CATEGORY DATA

  • Table 92 Sales of Weight Management by Category: Value 2005-2010
  • Table 93 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 94 Weight Management Company Shares 2006-2010
  • Table 95 Weight Management Brand Shares 2007-2010
  • Table 96 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 97 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Azerbaijan - Category Analysis

HEADLINES

TRENDS

  • Towards the end of the review period, the further growth was driven by the wide availability of all types of wound care products, mostly sticking plasters, through pharmaceutical stores. The culture of using sticking plasters, even in the case of minor wounds, has improved. During 2009-2010 Betasan entered Ramstore supermarket promoting its sticking plaster under the Sanitabant brand.

COMPETITIVE LANDSCAPE

  • Seyitler Kimya Sanayi AS was the leading player in wound care in 2010, holding a 35% value share with the Pelikan brand. It is followed by Betasan AS with the Sanitabant and Santavik brands. All those brands are very popular among a wide consumer base.

PROSPECTS

  • Wound care is expected to see a CAGR of 3% to account for AZN62,000 in constant value terms in 2015. The share of mid-priced and premium products will gradually increase, since consumers will search for more specific products. Hence, in the mid- to long-term forecast period, new launches are expected to concentrate on packaging and design, aimed at children, adult foot care and so on. First aid kits brands are also expected to enter in the mid-term forecast period; mostly underpinned by the intention to have such kits by car owners.

CATEGORY DATA

  • Table 98 Sales of Wound Care by Category: Value 2005-2010
  • Table 99 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 100 Wound Care Company Shares 2006-2010
  • Table 101 Wound Care Brand Shares 2007-2010
  • Table 102 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 103 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking incidence

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Future Demographic

      Consumer Lifestyle

      Country Report